Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0948265 (
metabolic syndrome
)
24,271
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In this issue of the journal, Brima et al. report thought-provoking research providing a potential evolutionary rationale whereby natural selection might have preserved genes that predispose to
metabolic syndrome
. When CD-1 mice were fed a high fat diet, this induced metabolic changes characteristic of
metabolic syndrome
. In addition, the high fat diet provided substantial protection from lethality due to infection with Trypanosoma cruzi. The authors hypothesize that the same genes predispose to both
metabolic syndrome
and protection against infectious disease. Thus, the selective advantage of not dying from infectious disease implicitly provides selective pressure predisposing to
metabolic syndrome
. This hypothesis follows a similar line of reasoning that has provided explanations for the survival of the HbS mutation for sickle cell disease and renal disease-associated genetic variants in
apolipoprotein L1
. Variants in these two genes provide protection from malaria and Trypanosoma brucei rhodesiense, respectively.
...
PMID:Metabolic syndrome: an ill wind that blows some good? 2561 19
Children are at increased risk of developing
metabolic syndrome
(MS) after kidney transplantation, which contributes to long-term cardiovascular (CV) morbidities and decline in allograft function. While MS in the general population occurs due to excess caloric intake and physical inactivity, additional chronic kidney disease and transplant-related factors contribute to the development of MS in transplant recipients. Despite its significant health consequences, the interplay of the individual components in CV morbidity in pediatric transplant recipients is not well understood. Additionally, the optimal methods to detect early CV dysfunction are not well defined in this unique population. The quest to establish clear guidelines for diagnosis is further complicated by genetic differences among ethnic groups that necessitate the development of race-specific criteria, particularly with regard to individuals of African descent who carry the
apolipoprotein L1
variant. In children, since major CV events are rare and traditional echocardiographic measures of systolic function, such as ejection fraction, are typically well preserved, the presence of CV disease often goes undetected in the early stages. Recently, new noninvasive imaging techniques have become available that offer the opportunity for early detection. Carotid intima-media thickness and impaired myocardial strain detected by speckle tracking echocardiography or cardiac magnetic resonance are emerging as early and sensitive markers of subclinical CV dysfunction. These highly sensitive tools may offer the opportunity to elucidate subtle CV effects of MS in children after transplantation. Current knowledge and future directions are explored in this review.
...
PMID:Cardiovascular effects of metabolic syndrome after transplantation: convergence of obesity and transplant-related factors. 2942 13